1) recurrent tumor
复发肿瘤
1.
This study aimed to determine the differences of prognosis between these treatments and the changes of the cytobiological characteristics between the primary and the recurrent tumor.
为了解不同消融治疗方法之间的差异及治疗后复发肿瘤与原发肿瘤之间细胞生物学的变化,本课题进行了以下三个阶段的研究。
2) recurrence
[英][rɪ'kʌrəns] [美][rɪ'kɝəns]
肿瘤复发
1.
The Prognostic Value of Serum Alpha Fetoprotein s Biological Half-life in Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma;
肝癌肝移植术后血清AFP生物半衰期对肿瘤复发的预测价值
2.
Objectives:To study the efficiency and safety of instillation with epirubicin(EPI) to prevent) postoperative recurrence of superficial bladdercancer.
结果表明术后即刻膀胱灌注大剂量法玛新,之后每三个月灌洗法玛新一次,可以使浅表性膀胱肿瘤复发率明显降低,而且法玛新膀胱灌洗的患者耐受性好、副反应发生率低。
3.
Find out the relation between complement regulator factor H and related protein and bladder tumor recurrence.
多因素分析各种临床病理因素与肿瘤复发间的关系。
4) Tumor recurrence
肿瘤复发
1.
Objective To explore the characteristics of tumor recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), including sites, time and risk factors of recurrence, and provide evidence for prediction and prevention of recurrence after LT, and evaluation of the recipient before LT.
目的探讨肝癌肝移植术后肿瘤复发的特点，包括复发部位、复发时间和危险因素，为预测和防治肝癌肝移植术后肿瘤复发及肝癌肝移植术前评估方法的改进提供依据。
2.
Conclusions:An elevated level of SCCAg in cervical cancer during the follow-up indicates tumor recurrence.
研究表明,宫颈癌随访期间血清SCCAg升高提示肿瘤复发,但并非所有随访SCCAg升高的宫颈癌患者经体格检查及传统影像均能探测到复发病灶。
补充资料：肿瘤转移复发的形成过程和基础
肿瘤转移复发的形成过程和基础
bas?is and formation of metastasis or recurrence of tumor
机制尚未明了，大概有下列方面：①存在具生物活性的肿瘤细胞及游离的肿瘤细胞；②癌细胞被体液、血流及淋巴液携带运行的渠道；③癌细胞停留于某一适宜生长部位，能黏附并穿过内皮层及穿过其外基质；④癌细胞生长繁殖。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条